Nanostring launches the cosmx 6,000 plex rna assay and showcases whole transcriptome imaging capability

Seattle--(business wire)-- #agbt2024--nanostring technologies, inc. (nasdaq: nstg), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the cosmx™ human 6k discovery panel, the industry's first single-cell spatial panel enabling research scientists to measure over 6,000 rna targets, representing nearly every human biological pathway. building on this breakthrough product developed for the cosmx spatial molecular imager (smi), nan.
NSTG Ratings Summary
NSTG Quant Ranking